Please enable JavaScript to continue using this application.

Compare $CRVO vs $ELTX | Chartloom

Compare

$CRVO vs $ELTX

CervoMed Inc · Elicio Therapeutics Inc

CRVO

CervoMed Inc

ELTX

Elicio Therapeutics Inc

Compare $CRVO vs $ELTX

Comparing CervoMed Inc and Elicio Therapeutics Inc

CRVOCervoMed Inc

ELTXElicio Therapeutics Inc

CRVOCervoMed Inc

Market cap

$44M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-95.7%

YTD performance

-58.7%

52W performance

-63.8%

FCF yield

-64.2%

ELTXElicio Therapeutics Inc

Market cap

$44M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-91.9%

YTD performance

-76.5%

52W performance

-82.0%

FCF yield

-86.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRVO

ELTX

Detailed metrics comparison

CRVO

CervoMed Inc

ELTX

Elicio Therapeutics Inc

Market Cap

CRVO$44M

ELTX$44M

Enterprise Value

CRVO$21M

ELTX$30M

Price

CRVO$3.22

ELTX$1.89

P/E Ratio

CRVON/A

ELTXN/A

P/S Ratio

CRVO131.50x

ELTX1.70x

EV/Sales

CRVO63.70x

ELTX0.00x

EV/EBITDA

CRVO0.00x

ELTX0.00x

P/B Ratio

CRVO1.99x

ELTX6.36x

P/FCF Ratio

CRVON/A

ELTXN/A

EV/FCF

CRVO-0.75x

ELTX-0.78x

PEG Ratio

CRVON/A

ELTXN/A

Forward P/E (NTM)

CRVON/A

ELTXN/A

Forward P/S (NTM)

CRVON/A

ELTXN/A

Revenue (TTM)

CRVO$331K

ELTX$0

Revenue Growth (YoY)

CRVO-95.7%

ELTX-91.9%

Forward Rev Growth

CRVO2153.6%

ELTX152.2%

Gross Margin (TTM)

CRVO0.0%

ELTX98.5%

Operating Margin (TTM)

CRVO0.0%

ELTX0.0%

EBITDA Margin (TTM)

CRVO-9406.8%

ELTX0.0%

Net Margin (TTM)

CRVO-9160.8%

ELTX0.0%

FCF Margin (TTM)

CRVO-8444.8%

ELTXN/A

Net Income (TTM)

CRVO$-30M

ELTX$-38M

FCF (TTM)

CRVO$-28M

ELTX$-38M

EPS (TTM)

CRVO-$2.96

ELTX-$1.97

ROE (TTM)

CRVO-15602.0%

ELTX-58297.0%

ROA (TTM)

CRVO-12834.0%

ELTX-13994.0%

ROIC (TTM)

CRVO-15602.0%

ELTX-18562.0%

Cash

CRVO$22M

ELTX$23M

Debt

CRVO$0

ELTX$10M

Net Cash/Debt

CRVO$22M

ELTX$14M

Current Ratio (TTM)

CRVO8.57x

ELTX2.77x

Quick Ratio (TTM)

CRVO8.36x

ELTX2.55x

Debt/Equity (TTM)

CRVO0.00x

ELTX1.20x

Debt/Assets (TTM)

CRVO0.0%

ELTX0.0%

Interest Coverage (TTM)

CRVON/A

ELTXN/A

Net Debt/EBITDA (TTM)

CRVO0.00x

ELTX0.00x

Beta

CRVO-0.69

ELTX1.65

52W Performance

CRVO-63.8%

ELTX-82.0%

YTD Performance

CRVO-58.7%

ELTX-76.5%

% from 52W High

CRVO-67.8%

ELTX-88.2%

% from 52W Low

CRVO51.2%

ELTX10.9%

Asset Turnover (TTM)

CRVO0.07x

ELTX0.33x

FCF Yield (TTM)

CRVO-64.2%

ELTX-86.7%

Earnings Yield (TTM)

CRVO-69.7%

ELTX-87.0%

Dividend Yield (TTM)

CRVON/A

ELTXN/A

Rule of 40

CRVO-8,540.5

ELTX-91.9

EV/GP/RG

CRVON/A

ELTXN/A

Ticker research

View CRVO research View ELTX research

Metric	CRVO CervoMed Inc	ELTX Elicio Therapeutics Inc
Market & Valuation
Market Cap	$44M	$44M
Enterprise Value	$21M	$30M
Price	$3.22	$1.89
P/E Ratio	N/A	N/A
P/S Ratio	131.50x	1.70x
EV/Sales	63.70x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.99x	6.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-0.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$331K	$0
Revenue Growth (YoY)	-95.7%	-91.9%
Forward Rev Growth	2153.6%	152.2%
Profitability
Gross Margin (TTM)	0.0%	98.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9406.8%	0.0%
Net Margin (TTM)	-9160.8%	0.0%
FCF Margin (TTM)	-8444.8%	N/A
Net Income (TTM)	$-30M	$-38M
FCF (TTM)	$-28M	$-38M
EPS (TTM)	-$2.96	-$1.97
ROE (TTM)	-15602.0%	-58297.0%
ROA (TTM)	-12834.0%	-13994.0%
ROIC (TTM)	-15602.0%	-18562.0%
Financial Health
Cash	$22M	$23M
Debt	$0	$10M
Net Cash/Debt	$22M	$14M
Current Ratio (TTM)	8.57x	2.77x
Quick Ratio (TTM)	8.36x	2.55x
Debt/Equity (TTM)	0.00x	1.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.69	1.65
52W Performance	-63.8%	-82.0%
YTD Performance	-58.7%	-76.5%
% from 52W High	-67.8%	-88.2%
% from 52W Low	51.2%	10.9%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.33x
FCF Yield (TTM)	-64.2%	-86.7%
Earnings Yield (TTM)	-69.7%	-87.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,540.5	-91.9
EV/GP/RG	N/A	N/A
Ticker research	View CRVO research	View ELTX research

Valuation

P/S Ratio

ELTX

1.70x

CRVO

131.50x

EV/FCF

ELTX

-0.78x

CRVO

-0.75x

Growth & revenue

Revenue Growth TTM

ELTX

-91.9%

CRVO

-95.7%

Forward Revenue Growth

CRVO

2153.6%

ELTX

152.2%

Profitability & performance

Gross Margin

ELTX

98.5%

CRVO

0.0%

ROE

CRVO

-15602.0%

ELTX

-58297.0%

FCF Yield %

CRVO

-64.2%

ELTX

-86.7%

52-Week Performance

CRVO

-63.8%

ELTX

-82.0%

Detailed metrics comparison

CRVO

CervoMed Inc

ELTX

Elicio Therapeutics Inc

Market Cap

CRVO$44M

ELTX$44M

Enterprise Value

CRVO$21M

ELTX$30M

Price

CRVO$3.22

ELTX$1.89

P/E Ratio

CRVON/A

ELTXN/A

P/S Ratio

CRVO131.50x

ELTX1.70x

EV/Sales

CRVO63.70x

ELTX0.00x

EV/EBITDA

CRVO0.00x

ELTX0.00x

P/B Ratio

CRVO1.99x

ELTX6.36x

P/FCF Ratio

CRVON/A

ELTXN/A

EV/FCF

CRVO-0.75x

ELTX-0.78x

PEG Ratio

CRVON/A

ELTXN/A

Forward P/E (NTM)

CRVON/A

ELTXN/A

Forward P/S (NTM)

CRVON/A

ELTXN/A

Revenue (TTM)

CRVO$331K

ELTX$0

Revenue Growth (YoY)

CRVO-95.7%

ELTX-91.9%

Forward Rev Growth

CRVO2153.6%

ELTX152.2%

Gross Margin (TTM)

CRVO0.0%

ELTX98.5%

Operating Margin (TTM)

CRVO0.0%

ELTX0.0%

EBITDA Margin (TTM)

CRVO-9406.8%

ELTX0.0%

Net Margin (TTM)

CRVO-9160.8%

ELTX0.0%

FCF Margin (TTM)

CRVO-8444.8%

ELTXN/A

Net Income (TTM)

CRVO$-30M

ELTX$-38M

FCF (TTM)

CRVO$-28M

ELTX$-38M

EPS (TTM)

CRVO-$2.96

ELTX-$1.97

ROE (TTM)

CRVO-15602.0%

ELTX-58297.0%

ROA (TTM)

CRVO-12834.0%

ELTX-13994.0%

ROIC (TTM)

CRVO-15602.0%

ELTX-18562.0%

Cash

CRVO$22M

ELTX$23M

Debt

CRVO$0

ELTX$10M

Net Cash/Debt

CRVO$22M

ELTX$14M

Current Ratio (TTM)

CRVO8.57x

ELTX2.77x

Quick Ratio (TTM)

CRVO8.36x

ELTX2.55x

Debt/Equity (TTM)

CRVO0.00x

ELTX1.20x

Debt/Assets (TTM)

CRVO0.0%

ELTX0.0%

Interest Coverage (TTM)

CRVON/A

ELTXN/A

Net Debt/EBITDA (TTM)

CRVO0.00x

ELTX0.00x

Beta

CRVO-0.69

ELTX1.65

52W Performance

CRVO-63.8%

ELTX-82.0%

YTD Performance

CRVO-58.7%

ELTX-76.5%

% from 52W High

CRVO-67.8%

ELTX-88.2%

% from 52W Low

CRVO51.2%

ELTX10.9%

Asset Turnover (TTM)

CRVO0.07x

ELTX0.33x

FCF Yield (TTM)

CRVO-64.2%

ELTX-86.7%

Earnings Yield (TTM)

CRVO-69.7%

ELTX-87.0%

Dividend Yield (TTM)

CRVON/A

ELTXN/A

Rule of 40

CRVO-8,540.5

ELTX-91.9

EV/GP/RG

CRVON/A

ELTXN/A

Ticker research

View CRVO research View ELTX research

Metric	CRVO CervoMed Inc	ELTX Elicio Therapeutics Inc
Market & Valuation
Market Cap	$44M	$44M
Enterprise Value	$21M	$30M
Price	$3.22	$1.89
P/E Ratio	N/A	N/A
P/S Ratio	131.50x	1.70x
EV/Sales	63.70x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.99x	6.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-0.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$331K	$0
Revenue Growth (YoY)	-95.7%	-91.9%
Forward Rev Growth	2153.6%	152.2%
Profitability
Gross Margin (TTM)	0.0%	98.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9406.8%	0.0%
Net Margin (TTM)	-9160.8%	0.0%
FCF Margin (TTM)	-8444.8%	N/A
Net Income (TTM)	$-30M	$-38M
FCF (TTM)	$-28M	$-38M
EPS (TTM)	-$2.96	-$1.97
ROE (TTM)	-15602.0%	-58297.0%
ROA (TTM)	-12834.0%	-13994.0%
ROIC (TTM)	-15602.0%	-18562.0%
Financial Health
Cash	$22M	$23M
Debt	$0	$10M
Net Cash/Debt	$22M	$14M
Current Ratio (TTM)	8.57x	2.77x
Quick Ratio (TTM)	8.36x	2.55x
Debt/Equity (TTM)	0.00x	1.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.69	1.65
52W Performance	-63.8%	-82.0%
YTD Performance	-58.7%	-76.5%
% from 52W High	-67.8%	-88.2%
% from 52W Low	51.2%	10.9%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.33x
FCF Yield (TTM)	-64.2%	-86.7%
Earnings Yield (TTM)	-69.7%	-87.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,540.5	-91.9
EV/GP/RG	N/A	N/A
Ticker research	View CRVO research	View ELTX research